Loading...
Loading...
Investing is risky. You might not know what you'll earn, it could be hard to sell, you might own less, unexpected things can happen, and you could lose all your money.
Medical Opinion Asia
Medical Opinion Asia (MOA) is an online platform providing medical second opinions to patients in the most efficient and easiest way possible. With their present team of 75 senior medical specialists, MOA aims to help everyone, from patients to insurance companies to corporate HR departments, in making medical decisions with confidence.
First-Mover Deal ! Within the first 30 days of the fundraising campaign, Medical Opinion Asia will reward investors with 10% additional shares from the promoters for all individual investments of RM25,000 and above. |
Medical Opinion Asia (MOA) is an online platform providing medical second opinions to patients in the most efficient and easiest way possible. With their present team of 75 senior medical specialists, MOA aims to help everyone, from patients to insurance companies to corporate HR departments, in making medical decisions with confidence.
First-Mover Deal ! Within the first 30 days of the fundraising campaign, Medical Opinion Asia will reward investors with 10% additional shares from the promoters for all individual investments of RM25,000 and above. |
MIN INVESTMENT
RM 5,000
MIN TARGET
RM 1,000,000
MAX TARGET
RM 3,000,000
SHARE TYPE
Ordinary Shares
SHARE PRICE
RM 50
VALUATION
RM 20,000,000
At Medical Opinion Asia (MOA), we all share a common dream: to bring healthcare to another level and share its benefits with everyone. With a team of healthcare professionals and senior medical specialists, our platform provides medical second opinions to the clients seeking them, allowing everyone to make medical decisions with confidence. Our core strength lies in our ability to connect our clients to senior medical specialists in the most time efficient way.
Starting out in 2016 as an online platform specifically for patients seeking second opinions, we expanded our clientele to fulfil demands from business-to-business market in 2017 after seeing the great demand for our medical opinion service. We have been growing from strength ever since and are now providing niche healthcare services to insurance companies, legal firms and corporates. We truly believe that better healthcare equates better productivity and profit, hence our services are tailored towards helping our clients achieve that aspiration.
Medical Opinion Asia. Make medical decisions with confidence.
Malaysians in general tend to shy away from asking questions or getting second opinions from other doctors on the diagnosis or recommended treatments by treating doctors and tend to agree with whatever treatment plans that have been proposed. Whilst some of them are afraid of getting second opinions thinking that it might upset the treating doctors, some just simply do not know who or where to turn to for second opinions. The truth is, you are in charge of your health, and have every right to get a second opinion, especially when facing these situations.
According to a study from the Mayo Clinic, up to 88% of patients seeking a second opinion receive a new or refined diagnosis. Although the benefits of getting second opinion are obvious, there is currently no service to help patients in Malaysia to get access to senior medical specialists for second opinions.
The conventional way of getting a second opinion is asking for a specialist recommendation from friends or family members and subsequently visiting the specialist after appointment is made. This method is time consuming and can be costly.
Malaysia’s healthcare costs are increasing at a double digit inflation rate, and the rate is expected to continue growing at fast pace. According to the global survey conducted by consulting and broking entity Mercer Marsh Benefits, Malaysia’s healthcare inflation stood at 11.5% in 2016 and was projected to rise to 12.7% in 2017. This number puts Malaysia as the third-highest among 11 Asian countries surveyed, behind India and Indonesia.
The continued rise in inflation rate must be addressed by insurance companies and corporates as it has a significant impact on the companies’ overall profit and financial performances.
Besides inflation, insurers are also facing the issue of insurance fraud, which continues to grow at alarming pace worldwide and costing insurance companies billions in loss. Frauds can be committed by policyholders by claiming for fake or exaggerated illnesses, injuries or disabilities, often involving huge sum of monies. Besides policyholders, frauds can also be orchestrated by medical practitioners. Overcharging in private hospitals has become common practice where medical fraud has reached an endemic level. It is not uncommon to see at least 20% in excess billing charges in private hospitals across the country.
European Healthcare Fraud and Corruption Network estimated that RM1.66 trillion (US$415 billion) is lost globally due to healthcare fraud each year.
Corporates are not spared from false claims. Employers often face the issue of recurring MCs, fake MCs and prolonged illnesses. In a 2014 report, the Malaysia Employers Federation revealed that employers lost RM2.9bil annually in overtime payments to workers who are replacing those on medical leave. If left unresolved, it will affect a company’s productivity and overall financial performance.
Medical Opinion Asia’s online platform provides the public with access to senior medical specialists for second opinions. Our specialists are currently practicing in major private medical centres in Malaysia and are carefully handpicked and invited to be in our panel. A patient can seek for a second opinion on the diagnosis and treatment from one of our specialists by completing the questionnaire and submitting all the relevant medical documents and images such as MRI, CT Scan, X-ray and Ultrasound. Our system will then automatically alert the selected specialist to provide his/her opinion. Opinion report will be provided by the specialist within 72 hours. Medical images uploaded by patients are viewed by our specialists using an integrated industry leading medical image viewing system, in lossless quality.
Using our platform, foreign patients can get a second opinion from a senior specialist first before coming over for treatment. After getting the second opinion, if the patient would like to come over to Malaysia for treatment, Medical Opinion will arrange for the concierge and appointment with the specialist.
B2B
Medical Opinion Asia helps insurance companies and corporates in healthcare cost containment by providing our niche healthcare solutions such as insurance medical opinion and independent medical examination (IME). Using our solutions, claim managers and HR managers can make better informed decisions, on whether or not to approve the claims from policyholders or employees and determining the return-to-work period for ill employees. Whenever a claim is deemed to be dubious, claim manager can request for medical opinion from our specialists for clarification on treatment procedure or bill. If IME is necessary, Medical Opinion Asia will arrange for it and a detailed report will be provided to the requester.
Studies show as many as 20% of patients seek second medical opinions; in specialties such as oncology, the rate is more than 50%. These numbers present a great market opportunity for Medical Opinion Asia as our online platform can be accessed globally. Our website is currently viewed from more than a hundred countries, via organic growth. We are already accepting second opinion requests from overseas such as Indonesia and New Zealand. As our second opinion pricing is comparatively super affordable compare to the western countries, we are expecting substantial number of requests when the marketing effort begins.
The medical tourism industry in Malaysia is booming. According to Transparency Market Research, the medical tourism market in Malaysia is forecasted to expand by a whopping 30.05% Compound Annual Growth Rate (CAGR) between 2016 and 2024. At this astonishing pace, the market will reach US$3.5 bn by the end of 2024, from a valuation of US$424.96 mn in 2016. The ever-growing influx of medical tourists from Indonesia, China, Saudi Arabia and other countries indicates massive opportunity for Medical Opinion Asia to grow exponentially in this space.
In Malaysia, there are more than 30 insurance companies with the national insurance penetration rate to breach 75% in 2020 from 56% in 2017. In 2016, there were 48,927 non-motor cases handled by adjusters in Malaysia.
There are 919 listed companies and 907,065 SME establishments in Malaysia. As indicated in the survey carried out by AIA in 2017, averagely, companies are suffering from 67 days loss of working days per employee per year due to absenteeism and presenteeism, and this leads to RM2.7mil lost per company per year.
These statistics presents a huge market for Medical Opinion Asia to tap in and grow our business.
Reaching out to the retail market by promoting brand awareness
Tie up with multiple legal firms for Medicolegal & Insurance Cases
Tie up with corporate HR departments for employees health management
The fund allocation breakdown details are as follows:
![[MOA] Pitch Deck 2018 (1).png](https://pxngcctamapirzokxdpu.supabase.co/storage/v1/object/public/deal-images/uploads/ozfmf3qqzdb-1787806538853.png)
Option 1 :
Investments can be done directly through this page by clicking on the ‘INVEST’ button.
Option 2 :
Alternatively, investments can also be made by depositing directly to the trustee account through :
For Option 2, please contact invest@medicalopinionasia.com to complete the investment process.
Chairman
Managing Director and Co-Founder
Director and Co-Founder
Director and Clinical Advisor
Chief Technology Officer
Medo Asia Sdn Bhd, a private limited company incorporated in Malaysia
Medical Opinion Asia (MOA) is an online platform providing medical second opinions to patients in the most efficient and easiest way possible. With their present team of 75 senior medical specialists, MOA aims to help everyone, from patients to insurance companies to corporate HR departments, in making medical decisions with confidence.
Ordinary Shares
90 days
The Issuer intends to raise up to RM 3,000,000 in this fundraising exercise.
RM 1,000,000
RM 3,000,000
RM 50 per share
20,000 shares
60,000 shares
RM 5,000
Retail, Angel, Sophisticated, and/or Institutional Investors, subject to the applicable investment limits prescribed under the Securities Commission’s Guidelines on Recognised Markets.
The proceeds are intended to be used for Marketing, Technological Development, Human Resources, and Operation. The funds will be transferred to the Issuer by the end of the Closing Date.
14 working days after the end of the Fundraising Period.
Investors may subscribe to ordinary shares through an Investment agreement.
The information, calculations and remarks expressed herein on this term sheet or any other parts of the platform are based on information provided, disclosed and presented by Medo Asia Sdn Bhd to Ata Plus Sdn Bhd, either in part or in whole. Ata Plus disclaim responsibility for the accuracy, completeness and/or validity of these information, hence will not be held liable for any inaccurate, inappropriate or incomplete information presented on this term sheet or on any other part of the platform subject to the following :
Should the Investor require more information, they can do so by contacting Medo Asia Sdn Bhd directly at invest@medicalopinionasia.com.
(i) No shares will be alotted or issued based on this document after six months from the closing of the offer period
(ii) This issue, offer or invitation for the offering is a proposal not requiring authorisation of the Securities Commission under section 212(8) of the CMSA 2007
(iii) This document has not been reviewed by the Securities Commission Malaysia. The Securities Commission does not recommend nor assumes responsibility for any information including any statement, opinion or report disclosed in relation to this fund raising exercise and makes no representation as to its accuracy or completeness. The Securities Commission expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information disclosed.
Investment Amount: RM 25,000 and above
Reward(s)
1. Eligible investors will receive an additional 10% shares* of the investment made
2. Eligibility:
*these are shares to be subscribed for and paid by the promoters, i.e. the existing shareholders of Medo Asia Sdn Bhd
Investment Amount: RM 5,000 to RM 9,999
Reward(s)
Investment Amount: RM 10,000 to RM 49,999
Reward(s)
Investment Amount: RM 50,000 to RM 99,999
Reward(s)
Investment Amount: RM 100,000 and above
Reward(s)
MOA Pitch Deck
MOA Pitch Deck
MOA Audited Accounts
MOA Audited Accounts
MOA Capitalisation Table
MOA Capitalisation Table
Sign in to access company documents and detailed information
Don't have an account? Register here
View our detailed presentation slides
RM 65,000
of RM 1,000,000
Min Target
RM 1,000,000
Max Target
RM 3,000,000
Investing in equity crowdfunding involves certain risks that include uncertainty of returns, lack of liquidity, dilution, material events and lack of control. Investments should be done as part of a diversified portfolio. ATA PLUS offers investment opportunities to investors who understands these risks in making their own investment decisions.
PLEASE READ THE FULL RISK WARNING BEFORE DECIDING TO INVEST.
This page is approved as a financial promotion by ATA PLUS Sdn. Bhd., which is authorized and regulated by the Security Commission of Malaysia. Deals that are up for investment are only offered to members of ata-plus.com on the basis of information provided by the companies concerned. ATA PLUS takes no responsibility for this information or for any recommendations or opinions made by the companies. For further information on this, please read our Term of Use.
RM 65,000
of RM 1,000,000
Min Target
RM 1,000,000
Max Target
RM 3,000,000
Min Investment
RM 5,000